Carasent AB (publ) (CARA.ST)

Sweden · Healthcare · SEK

Key financials

ROE: 4.08%; 2025 (actual)
ROA: 3.44%; 2025 (actual)
Gross Margin: 84.06%; 2025 (actual)
Net Margin: 10.08%; 2025 (actual)
Total Assets: SEK 941,006.00K; 2025 (actual)
Net Income: SEK 34,670.00K; 2025 (actual)
Valuation: SEK 1,835,150.67K; 2025 (actual)
Stock Price: SEK 27.45; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	4.08%	3.86%	4.18%	4.46%	4.73%	4.79%
ROA	3.44%	3.32%	3.58%	3.79%	3.99%	4.02%
Gross Margin	84.06%	84.06%	84.06%	84.06%	84.06%	84.06%
Sector average	16.85%	17.71%	17.71%	17.71%	17.71%	17.71%
Net Margin	10.08%	8.94%	9.02%	8.74%	8.66%	8.62%

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Carasent AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	SEK 941,006.00K	SEK 976,425.12K	SEK 1,024,354.82K	SEK 1,082,015.04K	SEK 1,142,517.68K	SEK 1,199,612.51K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K

Net Income	SEK 34,670.00K	SEK 31,830.64K	SEK 35,831.33K	SEK 39,967.29K	SEK 44,372.25K	SEK 47,098.10K
Sector average	-SEK 2,851.32K	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K

Valuation	SEK 1,835,150.67K	SEK 1,873,303.47K	SEK 1,910,738.57K	SEK 1,947,438.47K	SEK 1,983,288.54K	SEK 2,019,637.38K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 27.45	SEK 28.02	SEK 28.58	SEK 29.13	SEK 29.67	SEK 30.21
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41